Ducatiman
Yes marine systems but a few years ago it morphed into a marine surveillance system provider. So far there are no significant competitors and multiple governments around the world with worries about their waters are engaging. The problems are mainly delays caused by dealing with governments (yuk!) and some issues around project funding.
(Sorry o/t) |
You need to be on drugs to invest in this GED, lol.
Yes, some very good UK co’s all getting shafted by the Govt and AIM.
I remain hopeful of reform in both. |
Ah that's better. Had my afternoon recovery kip. Drugs knock me out.
Yes SRT I've just started looking at along with VEL. And we think this country has no industry. Looks to me as though UK has some pretty good companies.
Now does TO need a bit of luck so FDBK can join the list of good companies? After all the software has been shown to be effective in reducing waiting lists. |
marine systems yump? |
While we’re on our other shares, SRT worth a look. I have the benefit of a long and frustrating investment from lower prices. However revenue is about to go from not much to around 100mln and not just this year.
A brokers note is eagerly awaited.
The Twitterati haven’t seen SRT yet and they don’t go on Proactive brown-nosers or Vox spoutings. |
Exactly Yump, thank you. Obviously has no sense of humour. Unprovoked and supercilious, did you ever, lol. You’d have thought I had launched into a personal attack.
Enjoy your watch masuran. |
Quick check on LSE I see there was some announcement about a change in ERF. I'll have a look later.
Thanks for both of those, Masurenguy. Both qualify for me with the low number of shares but I notice both have gaps in the charts and SAAS is overbought at the moment but I will do further research once I've read the annual reports.
FDBK also has a gap but at least it is at a higher price 28p-40p
Since you've mentioned other shares I was thinking about ENSI, FTC, CNC, ONDO and even have CRDL (not sure)on my watchlist |
It would probably help if you hadn’t copy and pasted stuff that we already knew, that is actually not dealing with the crux of the matter.
It is what is not said or specified in a long series of RNS’, that matters.
See my post 11701.
In particular the ERF announcement sounds great but its worth thinking through the practicalities of the announcement.
I suggest some reading about the ERF and the way in which trusts have used its financing in the past.
Please don’t rely on TO or FDBK to hand out transparent announcements.
They also “disappearR21; from announcements, anything that isn’t going well, despite bleating about it previously.
Even at historic lows, if I wasn’t invested, I’d be looking elsewhere for a business I could trust to accept the reality themselves, let alone be honest with us. |
Your unprovoked and supercilious post says far more about you than I ever could. |
“I have added Fdbk to my watchlist”. lol. |
Interesting perspective Ged5. As author of the thread you have clearly followed the story for the past 6 years. We all draw our own conclusions and make our own investment decisions. At this time I have added FDBK to my watchlist and will follow its ongoing developments with interest.
Incidentally, "I'll look at more intersting tech companies that are getting contracts. There's quite a few of them." you might like to checkout BKS & SAAS. |
No its not early stage.
Renewal of the ERF this March is critical - lost amongst the general noise.
Also easy to forget that FDBK get paid per person for the latest digital initiative, so that could be after the event (eg. a year) in arrears, unless an NHS contract with £ appears. |
Thanks Ducatiman. Left knee recovery is already better than right knee recovery two years ago. But it couldn't have been worse than that!
Masurenguy, interesting points indeed but have you examined the wording?
ID1 CAN doesn't mean FDBK will get anything
ID2 HOPE PILOT HOPEFULLY So far as I can see Rohit hasn't achieved anything fr the bottom line.
ID3 Institutions haven't got a good track record here but they like speculating with other people's money
This CEO is an expert at dangling carrots. He really is a smooth operator but we've seen it all before. I'll hold a small amount just in case they get off their backsides and work for some contracts but until then I'll look at more intersting tech companies that are getting contracts. There's quite a few of them. |
Had a total knee replacement last Tuesday and I think I've had too much codeine and morphine because I'm catching up here and read two posts which taken in isolation paint a reasonably positive picture. But they were posted by Masurenguy who is usually a little more astute.
You two are just cynics! |
The remuneration committee would be good value Yump. |
Just curious but can you hire FDBK BOD members as speakers for events? - only our local social club has a few gaps for comedy half hours. |
Feedback raised £5.6m in a new placing @20p last November. On the 30th of November the company's net cash was £7.3m. The current share price is 19.7p, which reflects a market cap of £8.6m. Therefore the EV is currently only £1.3m and this significantly discounts the actual value potential ascribed to the business. |
Current Institutional Shareholdings
Unicorn Asset Management: 6,928,571. 15.81%
Amati Global Investors: 5,000,000. 11.41%
Cannacord Genuity Group: 3,750,000. 8.56%
Premier Miton Group: 3,054,143. 6.97%
Octopus Investments Nominees: 1,953,570. 4.46%
Sub Total: 47.21% |
Small discussion of Feedback at the 48 minute mark.
Feedback Medical's Rohit Singh will be speaking on the future of clinical communication in Kerala. |
Thats not really an “argument̶1; that addresses my point is it?
You could try using some reasoning, on how the “no barriers” will be demonstrated.
Afaik, Gandalf is fictional. |
You clearly don't know what you are talking about. |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
